Getinge Interim Report April-June 2026: Good organic growth, high profitability and strong cash flow

EarningsPositive

AI Analysis

Summary

Getinge reported strong quarterly results for April-June 2026 with good organic growth, high profitability, and strong cash flow, with increased sales across most Acute Care Therapies product categories.

Importance:3/10

Sentiment:

0.70

earningsquarterly resultsAcute Care Therapiesorganic growthcash flow

Read the original article

Published by PR Newswire Pharma on July 17, 2026 6:35 AM

Read Original